Literature DB >> 3950029

Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion?

L J Brown, M Wells.   

Abstract

Recent studies have described premalignant changes in the endocervical epithelium, but morphological criteria for the diagnosis of cervical glandular atypia of lesser severity than adenocarcinoma in situ have not been established. Adenocarcinoma in situ is often associated with cervical intraepithelial neoplasia (CIN). The endocervical mucosa in 105 cases of CIN grade III was evaluated and compared with that of 100 controls. Sixteen cases of cervical glandular atypia and one case of adenocarcinoma in situ were identified, and it was possible to discriminate between these and a range of benign glandular lesions. Interestingly, the control series included two patients with cervical glandular atypia, one of whom on review had had a cone biopsy for CIN. The progression of cervical glandular atypia through adenocarcinoma in situ to invasive adenocarcinoma is known, but the natural history of cervical glandular atypia is as yet uncertain.

Entities:  

Mesh:

Year:  1986        PMID: 3950029      PMCID: PMC499608          DOI: 10.1136/jcp.39.1.22

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Pituitary ablation for diabetic retinopathy. II. Results of yttrium 90 implantation in the pituitary gland.

Authors:  B S Ray; A G Pazianos; E Greenberg; W L Peretz; J M McLean
Journal:  JAMA       Date:  1968-01-08       Impact factor: 56.272

2.  Simultaneous in situ squamous cell carcinoma and microinvasive adenocarcinoma of the cervix.

Authors:  B M Wolk; W Kime; V Albites
Journal:  Int J Gynaecol Obstet       Date:  1981-03       Impact factor: 3.561

3.  Coexistent squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Authors:  Y C Choo; B Naylor
Journal:  Gynecol Oncol       Date:  1984-02       Impact factor: 5.482

4.  Intestinal metaplasia with argentaffin cells in the uterine cervix.

Authors:  J E Trowell
Journal:  Histopathology       Date:  1985-05       Impact factor: 5.087

5.  Morphology of adenocarcinoma in situ of the uterine cervix: a study of 14 cases.

Authors:  E Gloor; J Ruzicka
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

6.  The morphogenesis of adenocarcinoma of the cervix-a complex pathological entity.

Authors:  M E Boon; R S Kirk; P E Rietveld-Scheffers
Journal:  Histopathology       Date:  1981-09       Impact factor: 5.087

7.  In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases.

Authors:  A H Qizilbash
Journal:  Am J Clin Pathol       Date:  1975-08       Impact factor: 2.493

8.  Adenocarcinoma in situ of the cervix: an underdiagnosed lesion.

Authors:  M E Boon; J P Baak; P J Kurver; S H Overdiep; G W Verdonk
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

9.  Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix.

Authors:  R C Maier; H J Norris
Journal:  Obstet Gynecol       Date:  1980-09       Impact factor: 7.661

10.  Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions.

Authors:  L Bousfield; F Pacey; Q Young; I Krumins; R Osborn
Journal:  Acta Cytol       Date:  1980 Jul-Aug       Impact factor: 2.319

View more
  10 in total

1.  Nucleolar organiser regions in adenocarcinoma in situ of the endocervix.

Authors:  J E Cullimore; T P Rollason; T Marshall
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

Review 2.  Endocervical glandular lesions: controversial aspects and ancillary techniques.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

3.  Ciliated/tubal-type in-situ and invasive endocervical adenocarcinoma: Report of three cases with limited follow-up and review of the literature.

Authors:  Shivali Marketkar; Joyce Ou; C James Sung; M Ruhul Quddus
Journal:  Gynecol Oncol Rep       Date:  2022-06-23

4.  Human papillomavirus DNA in glandular lesions of the uterine cervix.

Authors:  H Samaratunga; N Cox; R G Wright
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

5.  p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.

Authors:  N Murphy; C C B B Heffron; B King; U G Ganuguapati; M Ring; E McGuinness; O Sheils; J J O'Leary
Journal:  Virchows Arch       Date:  2004-09-18       Impact factor: 4.064

6.  Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri with particular reference to adenocarcinoma in situ.

Authors:  T P Rollason; P Byrne; A Williams; G Brown
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

7.  Coexistence of early microinvasive endometrioid adenocarcinoma and CIN3 in the uterine cervix in a 32-year-old Japanese woman.

Authors:  Tadashi Terada
Journal:  Diagn Pathol       Date:  2011-06-10       Impact factor: 2.644

8.  Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix.

Authors:  Jobran M Moshi; Klaas J Hoogduin; Monique Ummelen; Mieke E R Henfling; Manon van Engeland; Kim A D Wouters; Hans Stoop; Imke Demers; Leendert H J Looijenga; Frans C S Ramaekers; Anton N H Hopman
Journal:  Cancer Med       Date:  2020-07-09       Impact factor: 4.452

9.  SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma.

Authors:  Anton N H Hopman; Jobran M Moshi; Klaas J Hoogduin; Monique Ummelen; Mieke E R Henfling; Manon van Engeland; Kim A D Wouters; Hans Stoop; Leendert H J Looijenga; Frans C S Ramaekers
Journal:  Histopathology       Date:  2019-12-01       Impact factor: 5.087

10.  Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.

Authors:  H P van de Nieuwenhof; L F A G Massuger; J A de Hullu; M A P C van Ham; J A A M van Dijck; A G Siebers; R L M Bekkers
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.